(Q39407370)

11 September 2017

0 references

1 reference

title

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis (English)

1 reference

11 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ahmed M A Altibi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Uyen N P Duong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Lewis Hassell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

30 June 2017

1 reference

11 September 2017

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

411-417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

Current thyroid cancer trends in the United States

2 June 2020

cites work

1 reference

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

21 January 2018

1 reference

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

21 January 2018

1 reference

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

21 January 2018

1 reference

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

21 January 2018

1 reference

TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.

21 January 2018

1 reference

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.

21 January 2018

1 reference

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

21 January 2018

1 reference

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer

21 January 2018

1 reference

In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.

21 January 2018

1 reference

A six-genotype genetic prognostic model for papillary thyroid cancer

21 January 2018

1 reference

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.

21 January 2018

1 reference

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.

21 January 2018

1 reference

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

21 January 2018

1 reference

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

21 January 2018

1 reference

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis

21 January 2018

1 reference

TERT Promoter Mutations in Thyroid Cancer

21 January 2018

1 reference

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis

21 January 2018

1 reference

BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas

21 January 2018

1 reference

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.13413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28666074%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference